UCI Health expands ENT and ophthalmology access

• February 13, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

• by Kathryn Wighton

• June 29, 2026

• 3 min

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk

• by Jess Allerton

• February 18, 2026

• 2 min

Epidemiology of eyelid disorders in an elderly population: Tehran Geriatric Eye Study

• by Hassan Hashemi, Alireza Mohammadi, Mohamadreza Aghamirsalim, Alireza Hashemi, Mehdi Khabazkhoob

• June 25, 2026